[1]
2020. Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s89. DOI:https://doi.org/10.25251/skin.4.supp.89.